Eptifibatide Dosage Guide: Research Protocols, Timing & Reconstitution

Standard Dosage Range

Research dosing range: Bolus: 180 mcg/kg IV; Infusion: 2 mcg/kg/min

Educational reference only

These dosage ranges are derived from preclinical research and community protocols. No human clinical dose-ranging trials have established therapeutic doses for most research peptides. Always consult a qualified healthcare provider before starting any peptide protocol.

Dosage by Use Case

Acute Coronary Syndrome (ACS) - Moderate to High Risk

180 mcg/kg IV bolus, followed by 2 mcg/kg/min infusionContinuous infusion

Duration

72-96 hours

Administered in conjunction with aspirin and unfractionated heparin or low-molecular-weight heparin. Renal function should be assessed and dosing adjusted accordingly.

Percutaneous Coronary Intervention (PCI) - High Risk

180 mcg/kg IV bolus prior to PCI, followed by 2 mcg/kg/min infusionContinuous infusion

Duration

18-24 hours post-PCI

A second bolus of 180 mcg/kg may be administered 10 minutes after the first bolus. Administered in conjunction with aspirin and heparin.

Renal Impairment (CrCl <50 mL/min) - ACS/PCI

180 mcg/kg IV bolus, followed by 1 mcg/kg/min infusionContinuous infusion

Duration

As indicated by clinical protocol

Reduce infusion rate by 50% in patients with creatinine clearance <50 mL/min to minimize the risk of bleeding. Monitor renal function closely.

Timing & Frequency

Eptifibatide has a rapid onset of action. The bolus is typically administered immediately prior to or at the start of the intervention. The continuous infusion is maintained per protocol.

Cycle Guidance

Eptifibatide is not typically used in long-term cycles. Its use is reserved for acute cardiovascular events and during PCI. Duration of infusion is dictated by clinical protocols.

Reconstitution Reference

Quick reference for reconstituting Eptifibatide. For custom vial sizes and concentrations, use the Reconstitution Calculator.

Common Vial Size	Typically available in 10 mL or 100 mL vials at a concentration of 0.75 mg/mL
BAC Water Volume	Not applicable, supplied as a sterile solution for IV administration
Concentration & Draw	0.75 mg/mL (750 mcg/mL)
Storage	Store at 2-8°C (36-46°F). Protect from light.
Stability	Refer to manufacturer's instructions. Typically stable until expiration date when stored properly.

Use the Reconstitution Calculator → for precise injection volumes based on your exact vial size, water volume, and desired dose.

Frequently Asked Questions

What is the standard eptifibatide dosage for PCI?

A bolus of 180 mcg/kg is administered intravenously prior to PCI, followed by a continuous infusion of 2 mcg/kg/min. A second bolus of 180 mcg/kg may be given 10 minutes after the first.

How is eptifibatide dosage adjusted for renal impairment?

In patients with creatinine clearance <50 mL/min, the infusion rate should be reduced by 50% to 1 mcg/kg/min.

What medications are typically used with eptifibatide?

Eptifibatide is typically administered in conjunction with aspirin and heparin (unfractionated or low-molecular-weight).

How long is eptifibatide infused for after PCI?

The continuous infusion is typically maintained for 18-24 hours post-PCI, depending on the clinical protocol.